Skip to main content

Advertisement

SpringerLink
Log in

Regulatory T-cells in the control of immunological diseases

  • Review Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

The immune system is challenged by randomly generated immune receptors that by chance can recognize self-antigens. Immunological tolerance functions as a fundamental concept in the control of a broad spectrum of immune responses not only to autoantigens but also to foreign antigens. During the past decade, CD4+CD25+ regulatory T-cells (Tregs) have emerged as key players in the development of immunological tolerance. This review will present an update on the current knowledge about the phenotype, function, and clinical relevance of this regulatory T-cell population. The therapeutical potential of Tregs to specifically suppress immune responses in autoimmunity and transplantation and their inhibitory effects in anti-tumor immune responses will be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kappler JW, Roehm N, Marrack P (1987) T-cell tolerance by clonal elimination in the thymus. Cell 49:273–280

    PubMed  CAS  Google Scholar 

  2. Kisielow P, Bluthmann H, Staerz UD, Steinmetz M, von Boehmer H (1988) Tolerance in T-cell receptor transgenic mice involves deletion of nonmature CD4+CD8+ thymocytes. Nature 333:742–746

    PubMed  CAS  Google Scholar 

  3. Gershon RK (1975) A disquisition on suppressor T-cells. Transplant Rev 26:170–185

    PubMed  CAS  Google Scholar 

  4. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T-cells expressing IL-2 receptor alpha chains (CD25): breakdown of a single mechanism of self tolerance causes various autoimmune diseases. J Immunol 155:1151

    PubMed  CAS  Google Scholar 

  5. Powrie F, Leach MW, Mauze S, Caddle LB, Coffman RL (1993) Phenotypically distinct subsets of CD4+ T-cells induce or protect from chronic intestinal inflammation in C.B-17 Scid mice. Int Immunol 5:1461–1471

    PubMed  CAS  Google Scholar 

  6. Hall BM, Pearce NW, Gurley KE, Dorsch SE (1990) Specific unresponsiveness in rats with prolonged cardiac allograft survival after treatment with cyclosporine. J Exp Med 171:141–157

    PubMed  CAS  Google Scholar 

  7. Sakaguchi S (2000) Regulatory T-cells: key controllers of immunologic self tolerance. Cell 101:455–458

    PubMed  CAS  Google Scholar 

  8. Shevach EM (2000) Regulatory T-cells in autoimmunity. Annu Rev Immunol 18:423–449

    PubMed  CAS  Google Scholar 

  9. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001) Identification and functional characterization of human CD4+CD25+ T-cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294

    PubMed  CAS  Google Scholar 

  10. Dieckmann D, Plottner H, Berchtold S, Berger T, Schuler G (2001) Ex vivo isolation and characterization of CD4+CD25+ T-cells with regulatory properties from human blood. J Exp Med 193:1303–1310

    PubMed  CAS  Google Scholar 

  11. Ng WF, Duggan PJ, Ponchel F, Matarese G, Lombardi G, Edwards AD, Isaacs JD, Lechler RI (2001) Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood 98(9):2736–2744

    PubMed  CAS  Google Scholar 

  12. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA (2001) CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167(3):1245–1253

    PubMed  CAS  Google Scholar 

  13. Seddiki N, Santner-Nanan B, Tangye SG, Alexander SI, Solomon M, Lee S, Nanan R, Fazekas de St Groth B (2006) Persistence of naive CD45RA+ regulatory T-cells in adult life. Blood 107(7):2830–2838

    PubMed  CAS  Google Scholar 

  14. Takahashi T, Kuniyasu Y, Toda M, Sakaguchi N, Itoh M, Iwata M, Shimizu J, Sakaguchi S (1998) Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T-cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 10:1969–1980

    PubMed  CAS  Google Scholar 

  15. Thornton AM, Shevach EM (2000) Suppressor effector function of CD4+CD25+ immunoregulatory T-cells is antigen non-specific. J Immunol 164:183–190

    PubMed  CAS  Google Scholar 

  16. Tanchot C, Vasseur F, Pontoux C, Garcia C, Sarukhan A (2004) Immune regulation by self-reactive T-cells is antigen specific. J Immunol 172:4285–4291

    PubMed  CAS  Google Scholar 

  17. Masteller EL, Warner MR, Tang Q, Tarbell KV, McDevitt H, Bluestone JA (2005) Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T-cells from nonobese diabetic mice. J Immunol 175:3053–3059

    PubMed  CAS  Google Scholar 

  18. Jaeckel E, von Boehmer H, Manns MP (2005) Antigen-specific Foxp3-transduced T-cells can control established type 1 diabetes. Diabetes 54:306–310

    PubMed  CAS  Google Scholar 

  19. Walker LS, Chodos A, Eggena M, Dooms H, Abbas AK (2003) Antigen-dependent proliferation of CD4+CD25+ regulatory T-cells in vivo. J Exp Med 198:249–258

    PubMed  CAS  Google Scholar 

  20. Klein L, Khazaie K, von Boehmer H (2003) In vivo dynamics of antigen specific regulatory T-cells not predicted from behavior in vitro. Proc Natl Acad Sci USA 100:8886–8891

    PubMed  CAS  Google Scholar 

  21. Cozzo C, Larkin J 3rd, Caton AJ (2003) Cutting edge: self-peptides drive the peripheral expansion of CD4+CD25+ regulatory T-cells. J Immunol 171(11):5678–5682

    PubMed  CAS  Google Scholar 

  22. Thornton AM, Shevach EM (1998) CD4+CD25+ immunoregulatory T-cells suppress polyclonal T-cell activation in vitro by inhibiting interleukin-2 production. J Exp Med 188:287–296

    PubMed  CAS  Google Scholar 

  23. Levings MK, Sangregorio R, Roncarolo MG (2001) Human CD25+CD4+ T regulatory cells suppress naive and memory T-cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193:1295–1302

    PubMed  CAS  Google Scholar 

  24. Suri-Payer E, Amar AZ, Thornton AM, Shevach EM (1998) CD4+CD25+ T-cells inhibit both the induction and effector function of autoreactive T-cells and represent a unique lineage of immunoregulatory cells. J Immunol 160:1212–1218

    PubMed  CAS  Google Scholar 

  25. Vlad G, Cortesini R, Suciu-Foca N (2005) Licence to heal: bidirectional interaction of antigen-specific regulatory T-cells and tolerogenic APC. J Immunol 174:5907–5914

    PubMed  CAS  Google Scholar 

  26. Cederbom L, Hall H, Ivars F (2000) CD4+CD25+ regulatory T-cells downregulate co-stimulatory molecules on antigen-presenting cells. Eur J Immunol 30:1538–1543

    PubMed  CAS  Google Scholar 

  27. Fallarino F, Gohmann U, Hwag KW, Orabona C, Vacca C, Bianchi R, Belladonna ML, Fioretti MC, Alegre ML, Pucetti P (2003) Modulation of tryptophan catabolism by regulatory T-cells. Nat Immunol 4:1206–1212

    PubMed  CAS  Google Scholar 

  28. Monagnoli C, Fallarino F, Gaziano R, Bozza S, Bellochio S, Zelante T, Kurup WP, Pitzurra L, Puccetti P, Romani L (2006) Immunity and tolerance to Aspergillus involve functionally distinct regulatory T cells and tryptophan catabolism. J Immunol 176(3):1712–1723

    Google Scholar 

  29. Tang Q, Boden EK, Henriksen KJ, Bour-Jordan H, Bi M, Bluestone JA (2004) Distinct roles of CTLA-4 and TGF-beta in CD4+CD25+ regulatory T-cell function. Eur J Immunol 34(11):2996–3005

    PubMed  CAS  Google Scholar 

  30. Hara M, Kingsley CI, Niimi M, Read S, Turvey SE, Bushell AR, Morris PJ, Powrie F, Wood KJ (2001) IL-10 is required for regulatory T-cells to mediate tolerance to alloantigens in vivo. J Immunol 166:3789–3796

    PubMed  CAS  Google Scholar 

  31. Hasieh CS, Liang Y, Tyznik AJ, Self SG, Liggitt D, Rudensky AY (2004) Recognition of the peripheral self by naturally arising CD25+CD4+ T-cell receptors. Immunity 21:267–277

    Google Scholar 

  32. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL (2002) CD4+CD25+ regulatory T-cells control Leishmania major persistence and immunity. Nature 420:502–507

    PubMed  CAS  Google Scholar 

  33. Seddon B, Mason D (2000) The third function of the thymus. Immunol Today 21(2):95–99

    PubMed  CAS  Google Scholar 

  34. Papiernik M, de Moraes ML, Pontoux C, Vasseur F, Penit C (1998) Regulatory CD4+ T-cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int Immunol 10(4):371–378

    PubMed  CAS  Google Scholar 

  35. Fischer K, Voelkl S, Heymann J, Przybylski GK, Mondal K, Laumer M, Kunz-Schughart L, Schmidt CA, Andreesen R, Mackensen A (2005) Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(−)CD8-double-negative regulatory T-cells. Blood 105(7):2828–2835

    PubMed  CAS  Google Scholar 

  36. Wakkach A, Fournier N, Brun V, Breittmayer JP, Cottrez F, Groux H (2003) Characterization of dendritic cells that induce tolerance and T regulatory 1 cell differentiation in vivo. Immunity 18(5):605–617

    PubMed  CAS  Google Scholar 

  37. Groux H, O’Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, Roncarolo MG (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389(6652):737–742

    PubMed  CAS  Google Scholar 

  38. Dieckmann D, Bruett CH, Ploettner H, Lutz MB, Schuler G (2002) Human CD4+CD25+ regulatory, contact-dependent T-cells induce interleukin-10-producing, contact-independent type 1-like regulatory T-cells (corrected). J Exp Med 196(2):247–253

    PubMed  CAS  Google Scholar 

  39. Thorstenson KM, Khoruts A (2001) Generation of anergic and potentially immunoregulatory CD25+CD4+ T-cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J Immunol 167(1):188–195

    PubMed  CAS  Google Scholar 

  40. Yamagiwa S, Gray JD, Hashimoto S, Horwitz DA (2001) A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T-cells from human peripheral blood. J Immunol 166(12):7282–7289

    PubMed  CAS  Google Scholar 

  41. Sparwasser T, Vabulas RM, Villmow B, Lipford GB, Wagner H (2000) Bacterial CpG-DNA activates dendritic cells in vivo: T helper cell-independent cytotoxic T-cell responses to soluble proteins. Eur J Immunol 30(12):3591–3597

    PubMed  CAS  Google Scholar 

  42. Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, Knop J, Enk AH (1997) Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 27(12):3135–3142

    PubMed  CAS  Google Scholar 

  43. Jonuleit H, Schmitt E, Schuler G, Knop J, Enk AH (2000) Induction of interleukin 10-producing, nonproliferating CD4+ T-cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 192(9):1213–1222

    PubMed  CAS  Google Scholar 

  44. Jonuleit H, Schmitt E, Steinbrink K, Enk AH (2001) Dendritic cells as a tool to induce anergic and regulatory T-cells. Trends Immunol 22(7):394–400

    PubMed  CAS  Google Scholar 

  45. Steinbrink K, Jonuleit H, Muller G, Schuler G, Knop J, Enk AH (1999) Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8+ T-cells resulting in a failure to lyse tumor cells. Blood 93(5):1634–1642

    PubMed  CAS  Google Scholar 

  46. Xia CQ, Peng R, Beato F, Clare-Salzler MJ (2005) Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity. Scand J Immunol 62(1):45–54

    PubMed  CAS  Google Scholar 

  47. Noble A, Giorginig A, Leggat JA (2006) Cytokine-induced IL-10-secreting CD8 T cells represent a phenotypically distinct suppressor T cell lineage. Blood (epub ahead of print)

  48. Sakaguchi S, Sakaguchi N, Shimizu J, Yamazaki S, Sakihama T, Itoh M, Kuniyasu Y, Nomura T, Toda M, Takahashi T (2001) Immunologic tolerance maintained by CD4+CD25+ regulatory T-cells: their common role in controlling autoimmunity, tumor immunity and transplantation tolerance. Immunol Rev 182:18–32

    PubMed  CAS  Google Scholar 

  49. Shimizu J, Yamazaki S, Takahashi T, Ishida Y, Sakaguchi S (2002) Stimulation of CD25+CD4+ regulatory T-cells through GITR breaks immunological self tolerance. Nat Immunol 3:135–142

    PubMed  CAS  Google Scholar 

  50. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, Byrne MC (2002) CD4+CD25+ immunoregulatory T-cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16:311–323

    PubMed  CAS  Google Scholar 

  51. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, Demengeot J (2003) Regulatory T-cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197(4):403–411

    PubMed  CAS  Google Scholar 

  52. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T-cell development by the transcription factor Foxp3. Science 299(5609):1057–1061

    PubMed  CAS  Google Scholar 

  53. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T-cells. Nat Immunol 4:330–336

    PubMed  CAS  Google Scholar 

  54. Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4(4):337–342

    PubMed  CAS  Google Scholar 

  55. Walker MR, Kasprowicz DJ, Gersuk VH, Benard A, Van Landeghen M, Buckner JH, Ziegler SF (2003) Induction of Foxp3 and acquisition of T regulatory activity by stimulated human CD4+CD25− T-cells. J Clin Invest 112(9):1437–1443

    PubMed  CAS  Google Scholar 

  56. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dyregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of Foxp3. Nat Genet 27:20–21

    PubMed  CAS  Google Scholar 

  57. Watanabe N, Wang YH, Lee HK, Ito T, Wang YH, Cao W, Liu YJ (2005) Hassall’s corpuscles instruct dendritic cells to induce regulatory CD4+CD25+ T-cells in human thymus. Nature 436:1181–1185

    PubMed  CAS  Google Scholar 

  58. Wan YY, Flavell RA (2005) Identifying Foxp3-expressing suppressor T-cells with a bicistronic reporter. Proc Natl Acad Sci USA 102:5126–5131

    PubMed  CAS  Google Scholar 

  59. Schubert LA, Jeffrey E, Zhang Y, Ramsdell F, Ziegler SF (2001) Scurfin (Foxp3) acts as a repressor of transcription and regulates T-cell activation. J Biol Chem 276:37672–37679

    PubMed  CAS  Google Scholar 

  60. Betelli E, Dastrange M, Oukka M (2005) Foxp3 interacts with nuclear factor of activated T-cells and NFêB T repress cytokine gene expression and effector functions of T helper cells. Proc Natl Acad Sci USA 102:5138–5143

    Google Scholar 

  61. Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M (2006) Inhibition of the transcription factor foxp3 converts desmoglein 3-specific type 1 regulatory T cells into th2-like cells. J Immunol 176(5):3215–3222

    PubMed  CAS  Google Scholar 

  62. Roncador G, Brown PJ, Maestre L, Hue S, Martinez-Torrecuadrada JL, Ling KL, Pratap S, Toms C, Fox BC, Cerundolo V, Powrie F, Banham AH (2005) Analysis of Foxp3 protein expression in human CD4+CD25+ regulatory T-cells at the single-cell level. Eur J Immunol 35(6):1681–1691

    PubMed  CAS  Google Scholar 

  63. Walunas TL, Lenschow DJ, Bakker CY, Linsley PS, Freeman GJ, Green JM, Thompson CB, Bluestone JA (1994) CTLA-4 can function as a negative regulator of T-cell activation. Immunity 1:405–413

    PubMed  CAS  Google Scholar 

  64. Wing K, Ekmark A, Karlsson H, Rudin A, Suri-Payer E (2002) Characterization of human CD25+CD4+ T-cells in thymus, cord and adult blood. Immunology 106(2):190–199

    PubMed  CAS  Google Scholar 

  65. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S (2000) Immunologic self tolerance maintained by CD4+CD25+ regulatory T-cells constitutively expressing CTLA-4. J Exp Med 192:303–310

    PubMed  CAS  Google Scholar 

  66. Jonuleit H, Schmitt E, Stassen M, Tuettenberg A, Knop J, Enk AH (2001) Identification and functional characterization of human CD4+CD25+ T-cells with regulatory properties isolated from peripheral blood. J Exp Med 193:1285–1294

    PubMed  CAS  Google Scholar 

  67. Bachmann MF, Kohler G, Ecabert B, Mak TW, Kopf M (1999) Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T-cell autonomous. J Immunol 163:1129–1131

    Google Scholar 

  68. Ueda H, Howson JM, Esposito L, Heward J, Snook H, Chamberlain G, Rainbow DB, Hunter KM (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423(6939):506–511

    PubMed  CAS  Google Scholar 

  69. Nocentini G, Giunchi L, Ronchetti S, Krausz LT, Bartoli A, Moraca R, Migliorati G, Riccardi C (1997) A new member of the tumor necrosis factor/nerve growth factor receptor family inhibits T-cell receptor-induced apoptosis. Proc Natl Acad Sci USA 94:6216–6221

    PubMed  CAS  Google Scholar 

  70. Uraushihara K, Kanai T, Ko K, Totsuka T, Makita S, Iiyama R, Nakamura T, Watanabe M (2003) Regulation of murine inflammatory bowel disease by CD25+ and CD25-CD4+ glucocorticoid-induced TNF receptor family-related gene+ regulatory T cells. J Immunol 171:708–716

    PubMed  CAS  Google Scholar 

  71. Levings MK, Sangregorio R, Sartirana C, Moschin AL, Battaglia M, Orban PC, Roncarolo MG (2002) Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin-10, and are distinct from type 1 T regulatory cells. J Exp Med 196(10):1335–1346

    PubMed  CAS  Google Scholar 

  72. Stassen M, Fondel S, Bopp T, Richter C, Muller C, Kubach J, Becker C, Knop J, Enk AH, Schmitt S, Schmitt E, Jonuleit H (2004) Human CD25+ regulatory T-cells: two subsets defined by the integrins alpha 4 beta 7 or alpha 4 beta 1 confer distinct suppressive properties upon CD4+ T helper cells. Eur J Immunol 34(5):1303–1311

    PubMed  CAS  Google Scholar 

  73. Schon MP, Schon M, Warren HB, Donohue JP, Parker CM (2000) Cutaneous inflammatory disorder in integrin alphaE (CD103)-deficient mice. J Immunol 165:6583–6589

    PubMed  CAS  Google Scholar 

  74. Huehn J, Siegmund K, Lehmann JC, Siewert C, Haubold U, Feuerer M, Debes GF, Lauber J, Frey O, Przybylski GK, Niesner U, de la Rosa M, Schmidt CA, Brauer R, Buer J, Scheffold A, Hamann A (2004) Developmental stage, phenotype and migration distinguish naive- and effector/ memory-like CD4+ regulatory T-cells. J Exp Med 199:303–313

    PubMed  CAS  Google Scholar 

  75. Berg EL, Goldstein LA, Jutila MA, Nakache M, Picker LJ, Streeter PR, Wu NW, Zhou D, Butcher EC (1989) Homing receptors and vascular addressins: cell adhesion molecules that direct lymphocyte traffic. Immunol Rev 108:5–18

    PubMed  CAS  Google Scholar 

  76. Bruder D, Probst-Kepper M, Westendorf AM, Geffers R, Beissert S, Loser K, von Boehmer H, Buer J, Hansen W (2004) Neuropilin-1: a surface marker of regulatory T-cells. Eur J Immunol 34(3):623–630

    PubMed  CAS  Google Scholar 

  77. Chorny A, Gonzalez-Rey E, Fernandez-Martin A, Pozo D, Ganea D, Delgado M (2005) Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. Proc Natl Acad Sci USA 102(38):13562–13567

    PubMed  CAS  Google Scholar 

  78. Sollwedel A, Bertoja AZ, Zenclussen ML, Gerlof K, Lisewski U, Wafula P, Sawitzki B, Woiciechowsky C, Volk HD, Zenclussen AC (2005) Protection from abortion by heme oxygenase-1 up-regulation is associated with increased levels of Bag-1 and neuropilin-1 at the fetal-maternal interface. J Immunol 175(8):4875–4885

    PubMed  CAS  Google Scholar 

  79. Fernandez-Martin A, Gonzalez-Rey E, Chorny A, Ganea D, Delgado M (2006) Vasoactive intestinal peptide induces regulatory T cells during experimental autoimmune encephalomyelitis. Eur J Immunol 36(2):318-326

    PubMed  CAS  Google Scholar 

  80. Loser K, Hansen W, Apelt J, Balkow S, Buer J, Beissert S (2005) In vitro-generated regulatory T cells induced by Foxp3-retrovirus infection control murine contact allergy and systemic autoimmunity. Gene Ther 12(17):1294–1304

    PubMed  CAS  Google Scholar 

  81. Morse SS, Sakaguchi N, Sakaguchi S (1999) Virus and autoimmunity: induction of autoimmune disease in mice by mouse T lymphotropic virus (MTLV) destroying CD4+ T-cells. J Immunol 162(9):5309–5316

    PubMed  CAS  Google Scholar 

  82. Elson CO, Cong Y, McCracken VJ, Dimmitt RA, Lorenz RG, Weaver CT (2005) Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Immunol Rev 206:260–276

    PubMed  Google Scholar 

  83. Itoh M, Takahashi T, Sakaguchi N, Kuniyasu Y, Shimizu J, Otsuka F, Sakaguchi S (1999) Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T-cells as a key function of the thymus in maintaining immunologic self-tolerance. J Immunol 162(9):5317–5326

    PubMed  CAS  Google Scholar 

  84. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA (2004) Loss of functional suppression by CD4+CD25+ regulatory T-cells in patients with multiple sclerosis. J Exp Med 199(7):971–979

    PubMed  CAS  Google Scholar 

  85. Liu MF, Wang CR, Fung LL, Wu CR (2004) Decreased CD4+CD25+ T-cells in peripheral blood of patients with systemic lupus erythematosus. Scand J Immunol 59(2):198–202

    PubMed  Google Scholar 

  86. Longhi MS, Ma Y, Bogdanos DP, Cheeseman P, Mieli-Vergani G, Vergani D (2004) Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease. J Hepatol 41(1):31–37

    PubMed  CAS  Google Scholar 

  87. de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, Albani S, Kuis W, Prakken B (2004) CD4+CD25bright regulatory T-cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172(10):6435–6443

    PubMed  Google Scholar 

  88. Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C (2003) Isolation and functional characterization of regulatory CD25brightCD4+ T-cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 33(1):215–223

    PubMed  CAS  Google Scholar 

  89. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C (2004) Compromised function of regulatory T-cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med 200(3):277–285

    PubMed  CAS  Google Scholar 

  90. Peterson P, Nagamine K, Scott H, Heino M, Kudoh J, Shimizu N, Antonarakis SE, Krohn KJ (1998) APECED: a monogenic autoimmune disease providing new clues to self-tolerance. Immunol Today 19(9):384–386

    PubMed  CAS  Google Scholar 

  91. Anderson MS, Venanzi ES, Klein L, Chen Z, Berzins SP, Turley SJ, von Boehmer H, Bronson R, Dierich A, Benoist C, Mathis D (2002) Projection of an immunological self shadow within the thymus by the aire protein. Science 298(5597):1395–1401

    PubMed  CAS  Google Scholar 

  92. Anderson MS, Venanzi ES, Chen Z, Berzins SP, Benoist C, Mathis D (2005) The cellular mechanism of aire control of T cell tolerance. Immunity 23(2):227–239

    PubMed  CAS  Google Scholar 

  93. Young NS, Maciejewski J (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336(19):1365–1372

    PubMed  CAS  Google Scholar 

  94. Dincol G, Aktan M, Nalcaci M, Yavuz AS, Keskin H, Dawson B, Dincol K (2001) Clonality of acquired pure red cell aplasia: effectiveness of antithymocyte globulin. Leuk Lymphoma 42(6):1413–1417

    Article  PubMed  CAS  Google Scholar 

  95. Hall AM, Ward FJ, Vickers MA, Stott LM, Urbaniak SJ, Barker RN (2002) Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood 100(13):4529–4536

    PubMed  CAS  Google Scholar 

  96. Kuwana M, Ikeda Y (2005) The role of autoreactive T-cells in the pathogenesis of idiopathic thrombocytopenic purpura. Int J Hematol 81(2):106–112

    PubMed  CAS  Google Scholar 

  97. Mqadmi A, Zheng X, Yazdanbakhsh K (2005) CD4+CD25+ regulatory T-cells control induction of autoimmune hemolytic anemia. Blood 105(9):3746–3748

    PubMed  CAS  Google Scholar 

  98. Bruder D, Westendorf AM, Hansen W, Prettin S, Gruber AD, Qian Y, von Boehmer H, Mahnke K, Buer J (2005) On the edge of autoimmunity: T-cell stimulation by steady-state dendritic cells prevents autoimmune diabetes. Diabetes 54(12):3395–3401

    PubMed  CAS  Google Scholar 

  99. Bruder D, Westendorf AM, Geffers R, Gruber AD, Gereke M, Enelow RI, Buer J (2004) CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions. Am J Respir Crit Care Med 170(11):1145–1152

    PubMed  Google Scholar 

  100. Westendorf AM, Templin M, Geffers R, Deppenmeier S, Gruber AD, Probst-Kepper M, Hansen W, Liblau RS, Gunzer F, Bruder D, Buer J (2005) CD4+ T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut 54(1):60–69

    PubMed  CAS  Google Scholar 

  101. Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. N Engl J Med 324(10):667–674

    Article  PubMed  CAS  Google Scholar 

  102. Chai JG, Xue SA, Coe D, Addey C, Bartok I, Scott D, Simpson E, Stauss HJ, Hori S, Sakaguchi S, Dyson J (2005) Regulatory T-cells, derived from naive CD4+CD25- T-cells by in vitro Foxp3 gene transfer, can induce transplantation tolerance. Transplantation 79(10):1310–1316

    PubMed  CAS  Google Scholar 

  103. Kingsley CI, Karim M, Bushell AR, Wood KJ (2002) CD25+CD4+ regulatory T-cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168(3):1080–1086

    PubMed  CAS  Google Scholar 

  104. Taylor PA, Noelle RJ, Blazar BR (2001) CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193(11):1311–1318

    PubMed  CAS  Google Scholar 

  105. Karim M, Kingsley CI, Bushell AR, Sawitzki BS, Wood KJ (2004) Alloantigen-induced CD25+CD4+ regulatory T-cells can develop in vivo from CD25−CD4+ precursors in a thymus-independent process. J Immunol 172(2):923–928

    PubMed  CAS  Google Scholar 

  106. Qin S, Cobbold SP, Pope H, Elliott J, Kioussis D, Davies J, Waldmann H (1993) “Infectious” transplantation tolerance. Science 259(5097):974–977

    PubMed  CAS  Google Scholar 

  107. Jonuleit H, Schmitt E, Kakirman H, Stassen M, Knop J, Enk AH (2002) Infectious tolerance: human CD25+ regulatory T-cells convey suppressor activity to conventional CD4+ T helper cells. J Exp Med 196(2):255–260

    PubMed  CAS  Google Scholar 

  108. Cobbold S, Waldmann H (1998) Infectious tolerance. Curr Opin Immunol 10(5):518–524

    PubMed  CAS  Google Scholar 

  109. Zeller JC, Panoskaltsis-Mortari A, Murphy WJ, Ruscetti FW, Narula S, Roncarolo MG, Blazar BR (1999) Induction of CD4+ T-cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-beta. J Immunol 163(7):3684–3691

    PubMed  CAS  Google Scholar 

  110. Graca L, Le Moine A, Lin CY, Fairchild PJ, Cobbold SP, Waldmann H (2004) Donor-specific transplantation tolerance: the paradoxical behaviour of CD4+CD25+ T-cells. Proc Natl Acad Sci USA 101(27):10122–10126

    PubMed  CAS  Google Scholar 

  111. Salama AD, Najafian N, Clarkson MR, Harmon WE, Sayegh MH (2003) Regulatory CD25+ T cells in human kidney transplant recipients. J Am Soc Nephrol 14:1643–1647

    PubMed  Google Scholar 

  112. Muthukumar T, Dadhania D, Ding R, Snopkowski C, Naqvi R, Lee JB, Hartono C, Li B, Sharma VK, Seshan SV, Kapur S, Hancock WW, Schwartz JE, Suthanthiran M (2005) Messenger RNA for Foxp3 in the urine of renal-allograft recipients. N Engl J Med 353(22):2342–2351

    PubMed  CAS  Google Scholar 

  113. Cohen JL, Trenado A, Vasey D, Klatzmann D, Salomon BL (2002) CD4+CD25+ immunoregulatory T-cells: new therapeutics for graft-vs.-host disease. J Exp Med 196:401–406

    PubMed  CAS  Google Scholar 

  114. Hoffmann P, Ermann J, Edinger M, Fathman CG, Strober S (2002) Donor-type CD4+CD25+ regulatory T-cells suppress lethal acute graft-versus-host disease after allogenic bone marrow transplantation. J Exp Med 196:389–399

    PubMed  CAS  Google Scholar 

  115. Taylor PA, Noelle RJ, Blazar BR (2001) CD4+CD25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade. J Exp Med 193:1311–1318

    PubMed  CAS  Google Scholar 

  116. Edinger M, Hoffmann P, Ermann J, Drago K, Fathman CG, Strober S, Negrin RS (2003) CD4+CD25+ regulatory T-cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Med 9:1144–1150

    PubMed  CAS  Google Scholar 

  117. Taylor PA, Lees CJ, Ehrhardt MJ et al (2003) Endogenous host or exogenous donor CD4+CD25+ cells promote donor BM engraftment: association with TGF-beta production and regulation of GITR signaling. Blood 102:37a, Abstract 117

    Google Scholar 

  118. Hanash AM, Levy RB (2003) Donor CD4+CD25+ T-cells facilitate hematopoietic engraftment independent of host resistance and allo-antigen recognition. Blood 102:38a, Abstract 120

    Google Scholar 

  119. Trenado A, Charlotte F, Fisson S, Yagello M, Klatzmann D, Salomon BL, Cohen JL (2003) Recipient-type specific CD4+CD25+ regulatory T-cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus-leukemia. J Clin Invest 112:1688–1696

    PubMed  CAS  Google Scholar 

  120. Miura Y, Thoburn CJ, Bright EC, Phelps ML, Shin T, Matsui EC, Matsui WH, Arai S, Fuchs EJ, Vogelsang GB, Jones RJ, Hess AD (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104(7):2187–2193

    PubMed  CAS  Google Scholar 

  121. Rieger K, Loddenkemper C, Maul J, Fietz T, Wolff D, Terpe H, Steiner B, Berg E, Miehlke S, Bornhauser M, Schneider T, Zeitz M, Stein H, Thiel E, Duchmann R, Uharek L (2006) Mucosal Foxp3+ regulatory T-cells are numerically deficient in acute and chronic GvHD. Blood 107(4):1717–1723

    PubMed  CAS  Google Scholar 

  122. Clark FJ, Gregg R, Piper K, Dunnion D, Freeman L, Griffiths M, Begum G, Mahendra P, Craddock C, Moss P, Chakraverty R (2004) Chronic graft-versus-host disease is associated with increased numbers of peripheral blood CD4+CD25high regulatory T-cells. Blood 103(6):2410–2416

    PubMed  CAS  Google Scholar 

  123. Zorn E, Kim HT, Lee SJ, Floyd BH, Litsa D, Arumugarajah S, Belucci R, Alyea EP, Antin JH, Soiffer RJ, Ritz J (2005) Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease. Blood 106(8):2903–2911

    PubMed  CAS  Google Scholar 

  124. Jiang S, Camara N, Lombardi G, Lechler RI (2003) Induction of allopeptide-specific human CD4+CD25+ regulatory T-cells ex vivo. Blood 102:2180–2186

    PubMed  CAS  Google Scholar 

  125. Hoffmann P, Eder R, Kunz-Schughart LA, Andreesen R, Edinger M (2004) Large-scale in vitro expansion of polyclonal human CD4+CD25high regulatory T-cells. Blood 104(3):895–903

    PubMed  CAS  Google Scholar 

  126. Rutella S, Pierelli L, Bonanno G, Sica S, Ameglio F, Capoluongo E, Mariotti A, Scambia G, Onofrio G, Leone G (2002) Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100(7):2562–2571

    PubMed  CAS  Google Scholar 

  127. Rutella S, Bonnano G, Pierelli L, Mariotti A, Capoluongo E, Comtem AM, Ameglio F, Curti A, Ritis DG, MT Voso, Perillo A, Mancuso S, Scambia G, Lemoli R, Leone G (2004) Granulocyte colony-stimulating factor promotes the generation of regulatory DC trough induction of IL-10 and IFN-α. Eur J Immunol 34:1291–1302

    PubMed  CAS  Google Scholar 

  128. Franzke A, Piao W, Lauber J, Gatzlaff P, Könecke C, Hansen W, Schmitt-thomsen A, Hertenstein B, Buer J, Ganser A (2003) G-CSF as immune regulator in T-cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102(2):734–739

    PubMed  CAS  Google Scholar 

  129. Pan L, Teshima T, Hill GR, Bungard D, Brinson YS, Reddy VS, Cooke KR, Ferrara JLM (1999) Granulocyte colony-stimulating factor-mobilized allogeneic stem cell transplantations maintains graft-versus-leukemia effects through a perforin-dependent pathway while preventing graft-versus-host-disease. Blood 93(12):4071–4078

    PubMed  CAS  Google Scholar 

  130. Kared H, Masson A, Adle-biassette H, Bach JF, Chatenoud L, Zavala F (2005) Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmocytoid dendritic cells and functional CD4+CD25+ regulatory T-cells. Diabetes 54:78–84

    PubMed  CAS  Google Scholar 

  131. Zou L, Barnett B, Safah H, LaRussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ, Zou W (2004) Bone marrow is a reservoir for CD4+CD25+ regulatory T-cells that traffic through CXCL12/CXCR4 signals. Cancer Res 64:8451–8455

    PubMed  CAS  Google Scholar 

  132. Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F, Boon T (2002) Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev 188:51–64

    Google Scholar 

  133. Kershaw MH, Teng MW, Smyth MJ, Darcy PK (2005) Supernatural T-cells: genetic modification of T-cells for cancer therapy. Nat Rev Immunol 5(12):928–940

    PubMed  CAS  Google Scholar 

  134. Sakaguchi S (2004) Naturally arising CD4+ regulatory T-cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531–562

    PubMed  CAS  Google Scholar 

  135. Onizuka S, Tawara I, Shimizu J, Sakaguchi S, Fujita T, Nakayama E (1999) Tumor rejection by in vitro administration of anti-CD25 monoclonal antibody. Cancer Res 59:3128–3133

    PubMed  CAS  Google Scholar 

  136. Shimizu J, Yamazaki S, Sakaguchi S (1999) Induction of tumor immunity by removing CD25+CD4+ T-cells: a common basis between tumor immunity and autoimmunity. J Immunol 163:5211–5218

    PubMed  CAS  Google Scholar 

  137. Yan ZZ, Novak TJ, Stenson MJ, Witzig TE, Ansell SM (2006) Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T-cells in B-cell non-Hodgkin lymphoma. Blood (epub ahead of print)

  138. Beyer M, Kochanek M, Giese T, Endl E, Weihrauch MR, Knolle PA, Classen S, Schultze JL (2006) In vivo peripheral expansion of naive CD4+CD25high FOXP3+ regulatory T cells in patients with multiple myeloma. Blood (epub ahead of print)

  139. Wolf AM, Wolf D, Steurer M, Gastl G, Gunsilius E, Grubeck-Loebenstein B (2003) Increase of regulatory T-cells in the peripheral blood of cancer patients. Clin Cancer Res 9:606–612

    PubMed  Google Scholar 

  140. Javia RL, Rosenberg SA (2003) CD4+CD25+ suppressor lymphocytes in the circulation of patients immunized against melanoma antigens. J Immunother 26:85–93

    PubMed  CAS  Google Scholar 

  141. Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH (2001) Regulatory CD4+CD25+ T-cells in tumors from patients with early-stage non-small cell lung cancer and late-state ovarian cancer. Cancer Res 61:4766–4772

    PubMed  CAS  Google Scholar 

  142. Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T-cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169(5):2756–2761

    PubMed  CAS  Google Scholar 

  143. Viguier M, Lemaitre F, Verola O, Cho MS, Gorochov G, Dubertret L, Bachelez H, Kourilsky P, Ferradini L (2004) Foxp3 expressing CD4+CD25(high) regulatory T-cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. J Immunol 173(2):1444–1453

    PubMed  CAS  Google Scholar 

  144. Marshall NA, Christie LE, Munro LR, Culligan DJ, Johnston PW, Barker RN, Vickers MA (2004) Immunosuppressive regulatory T-cells are abundant in the reactive lymphocytes of Hodgkin lymphoma. Blood 103(5):1755–1762

    PubMed  CAS  Google Scholar 

  145. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, Evdemon-Hogan M, Conejo-Garcia JR, Zhang L, Burow M, Zhu Y, Wei S, Kryczek I, Daniel B, Gordon A, Myers L, Lackner A, Disis ML, Knutson KL, Chen L, Zou W (2004) Specific recruitment of regulatory T-cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942–949

    PubMed  CAS  Google Scholar 

  146. Sasada T, Kimura M, Yoshida Y, Kanai M, Takabayashi A (2003) CD4+CD25+ regulatory T-cells in patients with gastrointestinal malignancies: possible involvement of regulatory T-cells in disease pregression. Cancer 98:1089–1099

    PubMed  Google Scholar 

  147. Ko K, Yamazaki S, Nakamura K, Nishioka T, Hirota K, Yamaguchi T, Shimizu J, Nomura T, Chiba T, Sakaguchi S (2005) Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T-cells. J Exp Med 202(7):885–891

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Hemostaseology and Oncology, Hannover Medical School, Hannover, Germany

    A. Franzke, J. K. Hunger & A. Ganser

  2. German Research Center for Biotechnology, Braunschweig, Germany

    K. E. J. Dittmar & J. Buer

  3. Institut of Medical Microbiology, Hannover Medical School, Hannover, Germany

    J. Buer

Authors
  1. A. Franzke
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. K. Hunger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. E. J. Dittmar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Ganser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Buer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Franzke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franzke, A., Hunger, J.K., Dittmar, K.E.J. et al. Regulatory T-cells in the control of immunological diseases. Ann Hematol 85, 747–758 (2006). https://doi.org/10.1007/s00277-006-0117-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-006-0117-1

Keywords

Search

Navigation